Global brain inflammation in stroke

K Shi, DC Tian, ZG Li, AF Ducruet, MT Lawton… - The Lancet …, 2019 - thelancet.com
Stroke, including acute ischaemic stroke and intracerebral haemorrhage, results in neuronal
cell death and the release of factors such as damage-associated molecular patterns …

Neuroinflammation in intracerebral haemorrhage: immunotherapies with potential for translation

M Xue, VW Yong - The Lancet Neurology, 2020 - thelancet.com
Intracerebral haemorrhage is inadequately controlled by current treatments, requiring new
solutions to improve the prognosis. Following the primary injury, a proinflammatory cascade …

Pathogenic mechanisms following ischemic stroke

SE Khoshnam, W Winlow, M Farzaneh, Y Farbood… - Neurological …, 2017 - Springer
Stroke is the second most common cause of death and the leading cause of disability
worldwide. Brain injury following stroke results from a complex series of pathophysiological …

The role of peripheral immune cells in the CNS in steady state and disease

M Prinz, J Priller - Nature neuroscience, 2017 - nature.com
The CNS is protected by the immune system, including cells that reside directly within the
CNS and help to ensure proper neural function, as well as cells that traffic into the CNS with …

Thrombo-inflammation in acute ischaemic stroke—implications for treatment

G Stoll, B Nieswandt - Nature Reviews Neurology, 2019 - nature.com
Ischaemic stroke elicits a strong neuroinflammatory response, but the functional relevance
and therapeutic potential of neuroinflammation has only recently become apparent. In acute …

[HTML][HTML] Microglial PGC-1α protects against ischemic brain injury by suppressing neuroinflammation

B Han, W Jiang, P Cui, K Zheng, C Dang, J Wang… - Genome Medicine, 2021 - Springer
Background Neuroinflammation and immune responses occurring minutes to hours after
stroke are associated with brain injury after acute ischemic stroke (AIS). PPARγ coactivator …

Targeted treatment of ischemic stroke by bioactive nanoparticle-derived reactive oxygen species responsive and inflammation-resolving nanotherapies

J Yuan, L Li, Q Yang, H Ran, J Wang, K Hu, W Pu… - ACS …, 2021 - ACS Publications
Stroke is a primary cause of death and disability worldwide, while effective and safe drugs
remain to be developed for its clinical treatment. Herein, we report bioactive nanoparticle …

Highly bioactive zeolitic imidazolate framework-8–capped nanotherapeutics for efficient reversal of reperfusion-induced injury in ischemic stroke

L He, G Huang, H Liu, C Sang, X Liu, T Chen - Science Advances, 2020 - science.org
Rational design of potent antioxidative agent with high biocompatibility is urgently needed to
treat ischemic reperfusion-induced ROS-mediated cerebrovascular and neural injury during …

Inhibition of double‐strand DNA‐sensing cGAS ameliorates brain injury after ischemic stroke

Q Li, Y Cao, C Dang, B Han, R Han, H Ma… - EMBO molecular …, 2020 - embopress.org
Cytosolic double‐stranded DNA (dsDNA) is a danger signal that is tightly monitored and
sensed by nucleic acid‐sensing pattern recognition receptors. We study the inflammatory …

Fingolimod protects against ischemic white matter damage by modulating microglia toward M2 polarization via STAT3 pathway

C Qin, WH Fan, Q Liu, K Shang, M Murugan, LJ Wu… - Stroke, 2017 - Am Heart Assoc
Background and Purpose—White matter (WM) ischemic injury, a major neuropathological
feature of cerebral small vessel diseases, is an important cause of vascular cognitive …